Global CHD Occluder Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global CHD Occluder market size was valued at US$ 284 million in 2024 and is forecast to a readjusted size of USD 426 million by 2031 with a CAGR of 6.1% during review period.

CHD occluders are medical devices intended for the closure of the remnant opening, or a defect, in the heart resulting from congenital abnormal development.

The coronary heart disease occluder market is driven by the increasing prevalence of coronary heart disease (CHD) and the demand for minimally invasive treatment options. CHD is a leading cause of morbidity and mortality worldwide, leading to the need for effective and safe treatment devices. Coronary heart disease occluders are specialized devices used in percutaneous procedures to close or occlude abnormal openings in the heart, such as septal defects or patent foramen ovale. These occluders offer advantages over traditional surgical methods, such as reduced procedural risks, shorter hospital stays, and quicker recovery times. Moreover, advancements in medical technology and imaging techniques have improved the accuracy and success rates of these procedures, contributing to market growth. However, the market also faces challenges, including the high cost of occluder devices and the need for specialized training for healthcare professionals performing these procedures. Additionally, the stringent regulatory approval process for medical devices poses obstacles to new market entrants. To succeed, manufacturers need to focus on cost-effectiveness, continuous innovation, and collaboration with healthcare providers to improve patient outcomes and expand their presence in the coronary heart disease occluder market.

This report is a detailed and comprehensive analysis for global CHD Occluder market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global CHD Occluder market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global CHD Occluder market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global CHD Occluder market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global CHD Occluder market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for CHD Occluder

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global CHD Occluder market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore & Associates, Starway, Coherex Medical, Cardia, MicroPort, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

CHD Occluder market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
ASD Occluder
VSD Occluder
PDA Occluder

Market segment by Application
Hospitals
Clinics

Major players covered
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe CHD Occluder product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of CHD Occluder, with price, sales quantity, revenue, and global market share of CHD Occluder from 2020 to 2025.

Chapter 3, the CHD Occluder competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the CHD Occluder breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and CHD Occluder market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of CHD Occluder.

Chapter 14 and 15, to describe CHD Occluder sales channel, distributors, customers, research findings and conclusion.